Academic Journal
Development and External Validation of a Machine Learning Model for Classification of Mild Cognitive Impairment and Dementia Using Clinical Data.
| Τίτλος: | Development and External Validation of a Machine Learning Model for Classification of Mild Cognitive Impairment and Dementia Using Clinical Data. |
|---|---|
| Συγγραφείς: | Kannenieks D; Faculty of Medicine, Riga Stradins University, LV-1007 Riga, Latvia., Priede Z; Department of Neurology and Neurosurgery, Riga Stradins University, LV-1002 Riga, Latvia., Millers A; Department of Neurology and Neurosurgery, Riga Stradins University, LV-1002 Riga, Latvia., Velins KK; Department of Mathematics, Imperial College London, London SW7 2AZ, UK. |
| Πηγή: | Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2026 Jul 14; Vol. 62 (7). Date of Electronic Publication: 2026 Jul 14. |
| Τύπος έκδοσης: | Journal Article |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet ISSN: 1648-9144 (Electronic) Linking ISSN: 1010660X NLM ISO Abbreviation: Medicina (Kaunas) Subsets: MEDLINE |
| Imprint Name(s): | Publication: 2018- : Basel, Switzerland : MDPI Original Publication: Kaunas : Lietuvos gydytojų sąjunga |
| Ιατρικοί όροι (MeSH): | Cognitive Dysfunction*/classification , Cognitive Dysfunction*/diagnosis , Machine Learning*/standards , Dementia*/classification , Dementia*/diagnosis, Humans ; Aged ; Retrospective Studies ; Male ; Female ; Boosting Machine Learning Algorithms ; Aged, 80 and over ; Cohort Studies ; Classification Algorithms ; Predictive Learning Models |
| Περίληψη: | Background and Objectives: As society ages, the number of patients with cognitive impairment is increasing. Machine learning methods that use structured clinical and cognitive-assessment data during routine diagnostic work-up may support and monitor structured classifications of cognitive status. This kind of approach can improve early screening, reduce physicians' workload and develop greater support for personalized treatment. To develop an XGBoost-based machine learning model using the National Alzheimer's Coordinating Center (NACC) dataset and to evaluate the model's precision with clinician-assigned diagnosis in a Latvian retrospective cohort study. Materials and Methods: The research was designed as a retrospective external validation cohort study that used two data sources. Firstly, the National Alzheimer's Coordination Center (NACC) longitudinal dataset was used to train the ML model. Secondly, medical records gathered from Pauls Stradins Clinical University Hospital dating from 2020 to May 2025 were used to evaluate the algorithm's precision. Results: In the NACC study, the weighted four-class model achieved an overall accuracy of 84.0% and a balanced accuracy of 70.9%, but the SCD class remained poorly classified. After reframing the model to a three-class model the performance grew stronger for normal cognition, mild cognitive impairment (MCI) and dementia. Class distribution in the Latvian cohort consisted of dementia (n = 138); MCI (n = 13); and subjective cognitive decline (SCD) (n = 2). Dementia was identified most strongly-124/138 (sensitivity-89.9%). MCI was correct in 9/13 cases (sensitivity-69.2%). SCD cases were excluded. Overall, the model agreed with the neurologist-assigned diagnoses in 88.1% of the cases (133/151). Conclusions: The ML classification model has high precision when comparing with neurologist-assigned diagnoses, but it struggles to separate adjacent early-stage diagnoses, meaning that it did not reliably identify SCD. These findings support further methodological development and the implementation of prospective research. Nevertheless, this technology has high potential for being integrated in the future to aid triage and early screening, especially when advanced diagnostics are limited. |
| References: | Geriatrics (Basel). 2022 Mar 08;7(2):. (PMID: 35314602) Ageing Res Rev. 2024 Nov;101:102497. (PMID: 39293530) Alzheimers Dement. 2014 Nov;10(6):844-52. (PMID: 24798886) Alzheimers Dement. 2018 Jun;14(6):734-742. (PMID: 29352855) J Alzheimers Dis. 2023;93(1):125-140. (PMID: 36938735) Eur J Neurol. 2020 May;27(5):894-899. (PMID: 32043740) Transl Psychiatry. 2021 Nov 9;11(1):576. (PMID: 34753917) Int J Nanomedicine. 2019 Jul 19;14:5541-5554. (PMID: 31410002) Cureus. 2023 Oct 4;15(10):e46454. (PMID: 37927664) Sci Rep. 2022 Apr 8;12(1):5979. (PMID: 35395867) NPJ Digit Med. 2022 Nov 7;5(1):171. (PMID: 36344814) Alzheimers Res Ther. 2020 Dec 18;12(1):167. (PMID: 33339532) |
| Grant Information: | P30 AG066515 United States AG NIA NIH HHS; P30 AG062421 United States AG NIA NIH HHS; P30 AG066508 United States AG NIA NIH HHS; P30 AG066519 United States AG NIA NIH HHS; P30 AG072973 United States AG NIA NIH HHS; P30 AG066462 United States AG NIA NIH HHS; P30 AG066530 United States AG NIA NIH HHS; P30 AG066509 United States AG NIA NIH HHS; P30 AG066546 United States AG NIA NIH HHS; P30 AG072958 United States AG NIA NIH HHS; P30 AG072972 United States AG NIA NIH HHS; P30 AG072979 United States AG NIA NIH HHS; P20 AG068082 United States AG NIA NIH HHS; P30 AG072975 United States AG NIA NIH HHS; P30 AG066444 United States AG NIA NIH HHS; P30 AG066507 United States AG NIA NIH HHS; P30 AG072946 United States AG NIA NIH HHS; P30 AG066518 United States AG NIA NIH HHS; P30 AG066511 United States AG NIA NIH HHS; P30 AG086404 United States AG NIA NIH HHS; P30 AG066512 United States AG NIA NIH HHS; P30 AG072978 United States AG NIA NIH HHS; P30 AG062429 United States AG NIA NIH HHS; P30 AG062422 United States AG NIA NIH HHS; R01 AG079280 United States AG NIA NIH HHS; P30 AG086401 United States AG NIA NIH HHS; P30 AG072977 United States AG NIA NIH HHS; P30 AG062677 United States AG NIA NIH HHS; P30 AG062715 United States AG NIA NIH HHS; P30 AG066506 United States AG NIA NIH HHS; P30 AG066468 United States AG NIA NIH HHS; P30 AG072976 United States AG NIA NIH HHS; P30 AG072947 United States AG NIA NIH HHS; P30 AG072931 United States AG NIA NIH HHS; P30 AG066514 United States AG NIA NIH HHS; P30 AG072959 United States AG NIA NIH HHS |
| Contributed Indexing: | Keywords: NACC dataset; SHAP analysis; XGBoost classification; early dementia detection; machine learning algorithm; mild cognitive impairment; subjective cognitive decline |
| Entry Date(s): | Date Created: 20260728 Date Completed: 20260729 Latest Revision: 20260824 |
| Update Code: | 20260824 |
| PubMed Central ID: | PMC13414067 |
| DOI: | 10.3390/medicina62071356 |
| PMID: | 42512898 |
| Βάση Δεδομένων: | MEDLINE |
| ISSN: | 1648-9144 |
|---|---|
| DOI: | 10.3390/medicina62071356 |